Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy-prone rat (GEPR): Transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine and serotonin

Molecular Brain Research

Volumn 43, Issue 1-2, 1996, Pages 233-245

  Szot, Patricia ^a,b   Reigel, Charles E ^c   White, Sylvia S ^a,b   Veith, Richard C ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

Author keywords

Dopamine transporter; Genetically epilepsy prone rat; In situ; mRNA; Neurotransporters; Norepinephrine transporter; Serotonin transporter; Tryptophan hydroxylase; Tyrosine hydroxylase

Indexed keywords

CARRIER PROTEIN; DOPAMINE; DOPAMINE TRANSPORTER; MESSENGER RNA; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; EPILEPSY; GENE EXPRESSION; LOCUS CERULEUS; MALE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SEIZURE SUSCEPTIBILITY; SUBSTANTIA NIGRA; TEGMENTUM; ZONA INCERTA;

ANIMALS; BIOGENIC MONOAMINES; DISEASE MODELS, ANIMAL; DOPAMINE; EPILEPSY; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN;

ANIMALIA;

EID: 0030608442     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00184-2     Document Type: Article

References (73)

1. 3H ]nisoxetine autoradiography, Brain Res., 582 (1992) 208-214.
2. Biguet, N.F., Buda, M., Lamouroux, A., Samolyk, D. and Mallet, J., Time course of the changes in TH mRNA in rat brain and adrenal medulla after a single injection of reserpine, EMBO J., 5 (1986) 287-291.
3. Blakely, R.D., Berson, H.E., Fremeau, R.T., Caron, M.G., Peek, M.M., Prince, H.K. and Bradley, C.C., Cloning and expression of a functional serotonin transporter from rat brain, Nature, 354 (1991) 66-70.
4. Browning, R.A., Neuroanatomical localization of structures responsible for seizures in the GEPR: lesion studies, Life Sci., 39 (1986) 857-867.
5. Browning, R.A., Hoffman, N.E. and Simonton, R.L., Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: the role of serotonergic neurons, Ann. NY Acad. Sci., 305 (1978) 437-456.
6. Browning, R.A., Wade, D.R., Marcinczyk, M., Long, G.L. and Jobe, P.C., Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat, J. Pharmacol. Exp. Ther., 249 (1989) 229-235.
7. Brudzynski, S.M., Cruickshank, J.W. and McLachlan, R.S., Cholinergic mechanisms in generalized seizures: importance of the zona incerta, Can. J. Neurol. Sci., 22 (1995) 116-120.
8. Bourne, W.M., Chin, L. and Picchioni, A.L., Enhancement of audiogenic seizure by 6-hydroxydopamine, J. Pharm. Pharmacol., 24 (1972) 913-914.
9. Buterbaugh, G.G. and London, E.D., The relationship between magnitude of electroshock stimulation and the effect of digitoxigenin, pentylenetetrazol and brain monoamine reduction on electroshock convulsive threshold, Neuropharmacology, 16 (1977) 617.
10. Calderini, G., Carlsson, A. and Nordstron, C.-H., Monoamine metabolism during bicuculline-induced epileptic seizures in the rat, Brain Res., 157 (1978) 295-302.
11. Chen, G., Ensor, G.R. and Bohner, B., A facilitation action of reserpine on the central nervous system, Proc. Soc. Exp. Biol. Med., 86 (1954) 507-510.
12. Clough, R.W., Browning, R.A., Maring, M.L. and Jobe, P.C., Intracerebral grafting of fetal dorsal pons in genetically epilepsy-prone rats: effects on audiogenic-induced seizures, Exp. Neurol., 112 (1991) 195-199.
13. Clough, R.W., Browning, R.A., Maring, M.L., Statnick, M.A., Wang, C. and Jobe, P.C., Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine, J. Neural Transplantation Plasticity, 5 (1994) 65-79.
14. Corcoran, M.E., Fibiger, H.C., McCaughran, J.A. and Wada, J.A., Potentiation of amygdaloid kindling and metrazol-induced seizures by 6-hydroxydopamine in rat, Exp. Neurol., 45 (1974) 118-133.
15. Dailey, J.W. and Jobe, P.C., Anticonvulsant drugs and the genetically epilepsy-prone rat, Fed. Proc., 44 (1985) 2640-2644.
16. Dailey, J.W. and Jobe, P.C., Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats, Epilepsia, 27 (1986) 665-670.
17. Dailey, J.W., Mishra, P.K., Ko, K.H., Penny, J.E. and Jobe, P.C., Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats, Life Sci., 50 (1991) 319-326.
18. Dailey, J.W., Mishra, P.K., Ko, K.H., Penny, J.E. and Jobe, P.C., Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rat, Epilepsia, 32 (1991) 168-173.
19. Dailey, J.W., Reigel, C.E., Mishra, P.K. and Jobe, P.C., Neurobiology of seizure predisposition in the genetically epilepsy-prone rat, Epilepsy Res., 3 (1989) 3-17.
20. Dailey, J.W., Seo, D.O., Yan, Q.S., Ko, K.H., Jo, M. and Jobe, P.C., The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study, Neurosci. Lett., 178 (1994) 179-183.
21. Dailey, J.W., Yan, Q.S., Adams-Curtis, L.E., Rys, J.R., Ko, K.H., Mishra, P.K. and Jobe, P.C., Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR), Life Sci., 58 (1996) 259-266.
22. Doretto, M.C., Burger, R.L., Mishra, P.K., Garcia-Cairasco, N., Dailey, J.W. and Jobe, P.C., A microdialysis study of amino acid concentrations in the extracellular fluid of the substantia nigra of freely behaving GEPR-9s: relationship to seizure predisposition, Epilepsy Res., 17 (1994) 157-165.
23. Eaton, M.J., Wagner, C.K., Moore, K.E. and Lookingland, K.J., Neurochemical identification of A13 dopaminergic neuronal projections from the medial zona incerta to the horizontal limb of the diagnol band of Broca and the central nucleus of the amygdala, Brain Res., 659 (1994) 201-207.
24. El-Etri, M.M., Ennis, M., Jiang, M. and Shipley, M.T., Pilocarpine-induced convulsions in rats: evidence for muscarinic receptor-mediated activation of locus coeruleus and norepinephrine release in cholinolytic seizure development, Exp. Neurol., 121 (1993) 24-39.
25. Faingold, C.L., Gehlbach, G. and Caspary, D.M., Decreased effectiveness of GABA-mediated inhibition in the inferior colliculus of the genetically epilepsy-prone rat, Exp. Neurol., 93 (1986) 145-159.
26. Fariello, R.G., DeMattei, M., Castorina, M., Ferraro, T.N. and Golden, G.T., MPTP and convulsive responses in rodents, Brain Res., 426 (1987) 373-376.
27. Fujita, M., Shimada, S., Maeno, H., Nishimura, T. and Tohyama, M., Cellular localization of serotonin transporter mRNA in the rat brain, Neurosci. Lett., 162 (1993) 59-62.
28. Grima, B., Lamouroux, A., Blanot, F., Biguet, N.F. and Mallet, J., Complete coding sequence of rat tyrosine hydroxylase mRNA, Proc. Natl. Acad. Sci. USA, 82 (1985) 617-621.
29. Hamdi, G.E., Boutroy, M.J. and Nehlig, A., Effects of pentylenetetrazol-induced seizures on dopamine and norepinephrine levels and on glucose utilization in various brain regions of the developing rat, Int. J. Dev. Neurosci., 10 (1992) 301-311.
30. Jobe, P.C., Ko, K.H. and Dailey, J.W., Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat, Brain Res., 290 (1984) 357-360.
31. Jobe, P.C. and Laird, H.E., Neurotransmitter abnormalities as determinants of seizure susceptibility and intensity in the genetic models of epilepsy, Biochem. Pharmacol., 30 (1981) 3137-3144.
32. Jobe, P.C., Picchioni, A.L. and Chin, L., Role of brain norepinephrine in audiogenic seizure in the rat, J. Pharmacol. Exp. Ther. 184 (1973) 1-10.
33. Kilty, J.E., Lorang, D. and Amara, S.G., Cloning and expression of a cocaine-sensitive rat dopamine transporter, Science, 254 (1991) 578-579.
34. Kim, K.S., Wessel, T.C., Stone, D.M., Carver, C.H., Joh, T.H. and Park, D.H., Molecular cloning and characterization of cDNA encoding tryptophan hydroxylase from rat serotonergic neurons, Mol. Brain Res., 9 (1991) 277-283.
35. Ko, K.H., Dailey, J.W. and Jobe, P.C., Effect of increments in norepinephrine concentrations on seizure intensity in the genetically epilepsy-prone rat, J. Pharmacol. Exp. Ther., 222 (1982) 662-669.
36. Ko, K.H., Dailey, J.W. and Jobe, P.C., Evaluation of monoaminergic receptors in genetically epilepsy prone rat, Experientia, 40 (1984) 70-73.
37. Lauterborn, J.C. and Ribak, C.R., Differences in dopamine B-hydroxylase immunoreactivity between the brains of genetically epilepsy-prone and Sprague-Dawley rats, Epilepsy Res., 4 (1989) 161-176.
38. Libet, B., Gleason, G.A., Wright, E.W. and Feinstein, B., Suppression of an epileptiform type of electrical activity in the rat by stimulation of the locus coeruleus, Epilepsia, 18 (1977) 451-462.
39. Lorang, D., Amara, S.G. and Simerly, R.B., Cell-type-specific expression of catecholamine transporters in the rat brain, J. Neurosci., 14 (1994) 4903-4914.
40. Mason, S.T. and Corcoran, M.E., Catecholamines and convulsions, Brain Res., 170 (1979) 497-507.
41. Millan, M.H., Meldrum, B.S., Boersma, C.A. and Faingold, C.L., Excitant amino acids and audiogenic seizures in the genetically epilepsy-prone rat. II. Efferent seizures propagating pathway, Exp. Neurol., 99 (1988) 687-698.
42. Meyerhoff, J.L., Carter, R.E., Yourick, D.L., Slusher, B.S. and Coyle, J.T., Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N- acetyl-aspartyl-glutamate, Brain Res., 593 (1992) 140-143.
43. Mishra, P.K., Burger, R.L., Bettendorf, A.F., Browning, R.A. and Jobe, P.C., Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus coeruleus with DSP-4, Exp. Neurol., 125 (1994) 58-64.
44. Mishra, P.K., Dailey, J.W., Reigel, C.E. and Jobe, P.C., Brain norepinephrine and convulsions in the genetically epilepsy-prone rat: sex-dependent response to Ro 4-1284 treatment, Life Sci., 42 (1988) 1131-1137.
45. Mishra, P.C., Kahle, E.H., Bettendorf, A.F., Dailey, J.W. and Jobe, P.C., Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe genetically epilepsy-prone rats (GEPR-9), Life Sci., 52 (1993) 1435-1441.
46. 1B receptor mRNA levels in rat brain, Brain Res., in press.
47. Pasini, A., Tortorella, A. and Gale, K., Anticonvulsant effect of intranigral fluoxetine, Brain Res., 593 (1992) 287-290.
48. Paxinos, G., The Rat Nervous System, 2nd edn., Academic Press, Orlando, FL, 1995.
49. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Orlando, FL, 1986.
50. Pocholczyk, T., Blakely, R.D. and Amara, S.G., Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter, Nature, 350 (1992) 350-354.
51. Prendiville, S. and Gale, K., Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats, Epilepsia, 34 (1993) 381-384.
52. Rattray, M., Wotherspoon, G., Savery, D., Baldessari, S., Marden, C., Priestley, J.V. and Bendotti, C., Chronic D-fenfluramine decreases serotonin transporter messenger RNA expression in dorsal raphe nucleus, Eur. J. Pharmacol - Mol. Pharmacol. Sect., 268 (1994) 439-442.
53. Reigel, C.E., Dailey, J.W. and Jobe, P.C., The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs, Life Sci., 39 (1986) 763-774.
54. Reigel, C.E., Whitehead, H., Lovering, A.T. and Lin, B.-K., Differential sensitivity to cocaine-induced seizures in two strains of the genetically epilepsy-prone rat (GEPR), Soc. Neurosci. Abstr., 21 (1995) 1965.
55. Salgado, D. and Alkadhi, K.A., Inhibition of epileptiform activity by serotonin in the rat CA1 neurons, Brain Res., 669 (1995) 176-182.
56. Salzman, P.M. and Roth, R.H., Poststimulation catecholamine synthesis and tyrosine hydroxylase activation in central noradrenergic neurons. I. In vivo stimulation of the locus coeruleus, J. Pharmacol. Exp. Ther., 212 (1980) 64-73.
57. Segal, M. and Bloom, F.E., The action of norepinephrine in the rat hippocampus. I. Iontophoretic studies, Brain Res., 72 (1974) 79-97.
58. Statnick, M.A., Dailey, J.W., Jobe, P.C. and Browning, R.A., Abnormalities in brain serotonin concentration, high-affinity uptake and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats, Epilepsia, 37 (1996) 311-321.
59. Stevens, J.R., Phillips, I., Freed, W.J. and Poltorak, M., Cerebral transplants for seizures: Preliminary results, Epilepsia, 29 (1988) 731-737.
60. Sullivan, H.C. and Osorio, I., Aggravation of penicillin-induced epilepsy in rats with LC lesion, Epilepsia, 32 (1991) 591-595.
61. Szot, P., Ashliegh, E.A., Kohen, R., Petrie, E., Dorsa, D.M. and Veith, R., Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment, Brain Res., 618 (1993) 308-312.
62. Szot, P. and Dorsa, D.M., Cytoplasmic and nuclear vasopressin RNA in hypothalamic and extrahypothalamic neurons of the Brattleboro rat: an in situ hybridization study, Mol. Cell. Neurosci., 3 (1992) 224-236.
63. Szot, P. and Veith, R.C., Pentylenetetrazol kindling results in sustained elevation in the expression of the norepinephrine transporter mRNA in the locus coeruleus, Soc. Neurosci. Abstr., 20 (1994) 924.
64. Trottier, S., Lindvall, O., Chauvel, P. and Bjorklund, A., Facilitation of focal cobalt-induced epilepsy after lesions of the noradrenergic LC system, Brain Res., 454 (1988) 308-314.
65. Wagner, C.K., Eaton, M.J., Moore, K.E. and Lookingland, K.J., Efferent projections from the region of the medial zona incerta containing A13 dopaminergic neurons: a PHA-L anterograde tract-tracing study in the rat, Brain Res., 677 (1995) 229-237.
66. Van Ness, P.C., Olsen, R.W. and Verity, M.A., MPTP is proconvulsant acutely but has no long-term effect in rodent models of seizure and epilepsy, Brain Res., 504 (1989) 289-292.
67. Wang, C., Mishra, P.K., Dailey, J.W., Jobe, P.C. and Browning, R.A., Noradrenergic terminal fields as determinants of seizure predisposition in GEPR-3: a neuroanatomic assessment with intracerebral microinjections of 6-hydroxydopamine, Epilepsy Res., 18 (1994) 1-9.
68. Yan, Q.S., Jobe, P.C. and Dailey, J.W., Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis, Brain Res., 610 (1993) 24-31.
69. Yan, Q.S., Jobe, P.C. and Dailey, J.W., Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat, Epilepsy Res., 14 (1993) 229-236.
70. Yan, Q.S., Jobe, P.C. and Dailey, J.W., Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats, Eur. J. Pharmacol., 252 (1994) 105-112.
71. Yan, Q.S., Mishra, P.K., Burger, R.L., Bettendorf, A.F., Jobe, P.C. and Dailey, J.W., Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats, J. Pharmacol. Exp. Ther., 261 (1992) 652-659.
72. Yu, A., Yang, J., Pawlyk, A.C. and Tejani-Butt, S.M., Acute depletion of serotonin down-regulates serotonin transporter mRNA in raphe neurons, Brain Res., 688 (1995) 209-212.
73. Zigmond, R.E., Tyrosine hydroxylase activity in noradrenergic neurons of the locus coeruleus after reserpine administration: sequential increase in cell bodies and nerve terminals, J. Neurochem., 32 (1979) 23-29.